AI assistant
Sending…
RYVU Therapeutics S.A. — Director's Dealing 2024
Dec 2, 2024
5798_rns_2024-12-02_7a3c6e14-fd91-47b9-a46a-c6ea5be0d204.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Notification on transaction/transactions* referred to
in Article 19(1) of MAR
| 1 | Data of the person discharging managerial responsibilities / person closely associated with such person |
||
|---|---|---|---|
| a) | Entity name/Last name | Hendrik Nogai | |
| 2 | Reason for submitting the notification | ||
| a) | Job title/status | Member of the Board of Management | |
| b) | Original notification / change | Original notification | |
| 3 | auction monitor | Data of the issuer, emission allowance market participant, auction platform, auctioneer or | |
| a) | Entity name | RYVU THERAPEUTICS SPÓŁKA AKCYJNA | |
| b) | LEI | 2594003WO9Q9HHAFL031 | |
| 4 | transaction type; (iii) each date; and (iv) each trading venue | Details of the transaction: please fill in this field for (i) each instrument type; (ii) each | |
| a) | Description of the financial instrument, instrument type Identification code |
Share PLSELVT00013 |
|
| b) | Transaction type | Issue of shares as part of the Stock Grant Program | |
| c) | Price and volume | Price | Volume |
| 0,19 PLN | 9000 | ||
| d) | Aggregate information - Total volume - Price |
9000 0,19 PLN |
|
| e) | Transaction date | 2024-11-29 | |
| f) | Trading venue | Out of trading |
* Delete as appropriate
Signed by / Podpisano przez: FRANZ HENDRIK DR. NOGAI Date / Data: 2024-12-02 15:12
More from RYVU Therapeutics S.A.
Interim / Quarterly Report
2026
May 21
Interim / Quarterly Report
2026
May 21
Interim / Quarterly Report
2026
May 21
Interim / Quarterly Report
2026
May 21
Regulatory Filings
2026
May 20
Management Reports
2026
May 20
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21